baber/WOPTO huggingface dataset:
Patent EP-0737308-B1 (EP)
Inventor: ROTH CHRISTOPH
IPC: G01N21/00
Filed: 1994-05-31
Granted: 1998-03-11
Abstract: L'invention porte sur un capteur optique de détection de substances chimiques consistant en un guide d'ondes optique plan à couche mince de guidage, et sur un appareil de détection de substances chimiques utilisant ledit capteur.
Patent EP-0662929-B1 (EP)
Title: Procede de recuperation d'acide sulfurique use contenant du sulfate de metal
Inventor: IYATOMI NOBUYOSHI
IPC: C23G1/36
Filed: 1994-07-22
Granted: 1997-10-22
Abstract: L'invention concerne un procédé permettant de régénérer efficacement et facilement une solution d'acide sulfurique présentant une concentration élevée et une faible teneur en impuretés, à partir d'une solution d'acide sulfurique usé et de la liqueur usée contenant du sulfate de métal, qui sont produits au cours d'une opération de nettoyage à l'acide et dégagés par le processus de production d'oxyde de titane (IV) réalisé selon le procédé à l'acide sulfurique. Ledit procédé consiste à éliminer le titane présent dans la solution d'acide sulfurique usé à l'aide d'un traitement d'extraction par solvant, la solution ainsi obtenue étant ensuite soumise à un traitement de dialyse diffusive.
Patent EP-0710248-B1 (EP)
Inventor: BOGDAHN ULRICH
IPC: A61P35/00
Filed: 1994-07-19
Granted: 1999-09-29
Abstract: New protein (I) with melanoma-inhibiting activity inhibits growth of cell lines HTZ 19-dm and ATCC CRL 1424. It is encoded by (a) 459 bp cDNA (IIa) or the corresponding 3565 bp genomic sequence (IIb), both reproduced in the specification, encoding a 131 amino acid protein which includes a 24 amino acid signal peptide, or (b) DNA sequences, or their fragments, able to hybridise with (IIa) or (IIb) in the region encoding the mature protein. Also new are (1) HTZ 19-dm (DSM ACC 2133); (2) (IIa) and (IIb), also sequences complementary to them, able to hybridise with them, or equiv. within the degeneracy of the genetic code; (3) recombinant expression vectors contg. such DNA and able to express (I) in transformed microorganisms or eukaryotic cells; (4) prokaryotic and eukaryotic cells able to express (I); (5) antibodies (Ab) raised against (I).
Patent EP-0724638-B1 (EP)
Inventor: SEKELLICK MARGARET J
IPC: C12N15/21
Filed: 1994-10-21
Granted: 2004-06-02
Abstract: The present invention relates to a chicken interferon gene coding for the amino acid sequence of SEQ ID NO: 1. The present invention also relates to a method of producing biologically active chicken interferon recombinantly, a method of isolating other non-mammalian interferon genes, a method of making a transgenic fowl having the chicken interferon gene incorporated therein, and method for delivery of the chicken interferon in the bird, such as by genetic immunization or aerosol. Expression of the chicken IFN gene yields functional chicken interferon.
Patent EP-0681819-B1 (EP)
Inventor: STEVENSON PHILIP J
IPC: A61F13/15
Filed: 1995-05-11
Granted: 1998-12-30
Abstract: Shaped absorbent articles, such as catamenial pads and diapers, with a raised portion in the body facing side are disclosed. The articles have one or more areas of adhesive, preferably in the form of longitudinal strips, disposed on the garment facing side for forming the raised portion. By folding the garment facing side toward itself, the adhesive area adheres to either itself or to the garment facing side, thereby creating a raised portion that, in the example of a catamenial pad, would conform to certain portions of the perineal region of the user. Methods of forming shaped absorbent articles are also disclosed. In accordance with the present invention, portions of the garment facing side of an absorbent article are folded to adhere to portions of the garment facing side or areas of adhesive to create a raised portion in the body facing side. <IMAGE>   <IMAGE>
Patent EP-0679399-B1 (EP)
Inventor: OGATA KAZUMI
IPC: A61K31/665
Filed: 1995-04-13
Granted: 1997-08-06
Abstract: Epidermis proliferative diseases are treated with a phosphoric diester compound of the following Formula I or a pharmacologically acceptable salt thereof. <CHEM> [wherein R1 and R2 are the same or different and each represents hydrogen or methyl].
Patent EP-0680695-B1 (EP)
Inventor: DOWNEY ANGELA BRIDGET
IPC: B27K3/50
Filed: 1995-04-24
Granted: 1998-11-04
Abstract: Synergistic microbicidal compositions are disclosed, comprising 4,5-dichloro-2-n-octyl-3-isothiazolone and 2-methylthio-4-tert-butylamino-6-cyclopropylamino-s-triazine or N,N-dimethyl-N'-phenyl-(N'-fluorodichloromethylthio)sulfamide for more effective, and broader control of microorganisms in various systems
Patent EP-0774448-B1 (EP)
Inventor: CHU MIKE SSU-HAI
IPC: H01G4/12
Filed: 1995-12-18
Granted: 1999-11-03
Abstract: A sinterable dielectric ceramic powder composition comprising 95 to 98 parts by weight of a major ingredient consisting of 97.0 to 99.5 mole % barium titanate, 0.5 to 3.0 mole% magnesium oxide or a precursor therefor and 0 to 2.0 mole% manganese oxide or a precursor therefor and 0 to 0.2 mole% cobalt oxide or a precursor therefor; 2 to 5 parts by weight of a minor ingredient consisting of a ternary mixture of 15 to 30 mole% barium oxide or a precursor therefor, 15 to 30 mole% silicon dioxide or a precursor therefor and 40 to 70 mole% calcium titanate, which composition can be fabricated into multilayer ceramic capacitors with nickel, nickel alloy, palladium or palladium/silver alloy inner electrodes, the so formed capacitors having a variation of capacitance with temperature of less than +/- 20% over the range -55 DEG C to 140 DEG C as compared to the value at 25 DEG C and not containing any second phases after sintering.
Patent EP-0726866-B1 (EP)
Inventor: HEGER SIEGFRIED
IPC: B65D88/12
Filed: 1994-11-02
Granted: 1997-07-16
Abstract: PCT No. PCT/DE94/01338 Sec. 371 Date Aug. 15, 1996 Sec. 102(e) Date Aug. 15, 1996 PCT Filed Nov. 2, 1994 PCT Pub. No. WO95/12536 PCT Pub. Date May 11, 1995A high-capacity container has a receiving bracket for a hook, adjustable support rollers, upper straps which form forklift pockets, wherein slide rails are located under a container floor and connected to receptacle supports, support rollers are located in corner areas below the container floor to be pivoted-in and pivoted-out to be positioned in the container and in a plane below the corners, while the forklift pocket includes upper and lower straps, and a reinforcement is provided between and in the slide rails and a frame profile in the area of the forklift pockets.
Patent EP-0730681-B1 (EP)
Inventor: MARCOLONGO MICHELE S
IPC: D04H13/00
Filed: 1994-11-14
Granted: 2002-08-28
Abstract: Composite materials formed from bone bioactive glass or ceramic fibers and structural fibers are disclosed. In preferred embodiments, a braid or mesh of interwoven bone bioactive glass or ceramic fibers and structural fibers is impregnated with a polymeric material to provide a composite of suitable biocompatibility and structural integrity. Most preferably, the mesh or braid is designed so that the bioactive fibers are concentrated at the surface of the implant to create a surface comprised of at least 30% bioactive material, thereby providing enhanced bone ingrowth. The interweaving between the bone bioactive glass or ceramic fibers and the core of structural fibers overcomes the problems found in prior composite systems where the bioactive material delaminates from the polymer. Preferred bioactive materials include calcium phosphate ceramics and preferred structural fibers include carbon fibers. Improved prosthetic implants and methods of affixing an implant are thus also disclosed.
Patent EP-0731894-B1 (EP)
Title: Isolant de tuyau a fermeture adhesive et son procede de fabrication
Inventor: HARTMAN DAVID
IPC: F16L59/10
Filed: 1994-12-01
Granted: 1998-08-19
Abstract: On décrit un procédé qui permet d'appliquer un ruban d'obturation sur un article extrudé en mousse. Le ruban (40) est appliqué juste après l'extrusion de l'article alors que celui-ci est encore sujet à rétraction, ce qui est courant pour les produits extrudés en mousse. Ce ruban est précontraint et son matériau lui permet d'atténuer les problèmes découlant de la contraction. Ce procédé convient particulièrement pour appliquer un ruban d'obturation sur un isolant (2) de tuyau réalisé en polyéthylène extrudé qui est fendu sur sa longueur pour enserrer ce tuyau. Ce ruban présente un côté fixé sur un côté de la fente (9), l'autre partie du ruban étant placée de façon à refermer cette fente en entrant en prise avec l'autre côté de celle-ci. Un adhésif sensible à la pression est disposé sur le ruban et une garniture amovible protège cet adhésif sur cette autre partie de ruban.
Patent EP-0739426-B1 (EP)
Inventor: DISCH GUENTHER
IPC: C21D1/667
Filed: 1995-01-11
Granted: 1998-04-15
Abstract: A process and device are disclosed for quenching workpieces (18). The workpieces (18) are exposed to a flow (26) of quenchant (12). The workpieces (18) and the quenchant (12) are reversibly moved in relation to each other. For that purpose, a first conveyor for the quenchant (12), in particular a pump (44), and a second conveyor, in particular a roller conveyor with transport rollers (16) for the workpieces (18), are designed with reversible transport directions.
Patent EP-0775093-B1 (EP)
Inventor: MAEHL DIETER
IPC: C02F3/06
Filed: 1995-05-24
Granted: 1999-03-24
Abstract: PCT No. PCT/NL95/00183 Sec. 371 Date Nov. 13, 1996 Sec. 102(e) Date Nov. 13, 1996 PCT Filed May 24, 1995 PCT Pub. No. WO95/32923 PCT Pub. Date Dec. 7, 1995A method and apparatus for the biochemical purification of a contaminated liquid medium, in which the liquid medium is passed through granular filter material provided in a holder and in which the granular filter material (12) contained in the holder is set in motion, preferably with the aid of an injected gas such as air. Microorganisms and/or an active water for microorganisms can be added to the holder. The filter material may comprise a mixture of lava and sand, for example 28% to 38% sand and 61% to 71% lava. The granule size of the sand is 0.3 to 1.2 mm and the granule size of the lava is 2 to 10 mm. The main flow of the medium to be purified and the injected gas are oppositely directed. To set the filter material in motion, use is made of an inner tube (33) placed in an outer tube (32), gas being blown through the inner tube under the lower end of the inner tube (31) so that gas and filter material drawn in at the lower end of the tubes and medium are transported upward through the inner tube.
Patent EP-0763177-B1 (EP)
Inventor: FAHRION OTMAR
IPC: F16M13/00
Filed: 1995-05-31
Granted: 1998-12-30
Abstract: On utilise des éléments asservis de soutien tels que des cylindres de travail (28) dont les chambres de travail sont en communication avec un conduit commun de compensation (64) afin de monter de manière aisément ajustable une pièce d'une rigidité non idéale et de grandes dimensions sur une infrastructure avec des forces de soutien prédéterminées, en particulier identiques s'exerçant sur les différents points de soutien.
Patent EP-0785986-B1 (EP)
Inventor: KRUSE WOLFGANG
IPC: C12P7/26
Filed: 1995-10-07
Granted: 2002-03-06
Abstract: In a process for the continuous enzyme-catalyticzed enzymatic production of hydrophobic products in an aqueous solution of a reaction mixture, the product is extracted from the product containing reaction mixture by way of a product-permeable microporous membrane into an organic solvent and the product-depleted reaction mixture is recycled.
Patent EP-0789776-B1 (EP)
Inventor: WELS WINFRIED
IPC: C12N15/62
Filed: 1995-10-31
Granted: 2001-06-13
Abstract: The invention pertains to a nucleic acid transfer system including a translocation domain of toxins, especially of diphtheria toxin suitable for targeting a nucleic acid, e.g. a gene, to a specific cell, and obtaining expression of said nucleic acid. The nucleic acid transfer system of the invention comprises a multidomain protein component and a nucleic acid component. Furthermore, the present invention relates to the multidomain protein, a nucleic acid encoding said protein, suitable amplification and expression systems for said nucleic acid, and processes for the preparation and uses of the above subject matters.
Patent EP-0795202-B1 (EP)
Inventor: GREEN MARTIN ANDREW
IPC: H01L31/04
Filed: 1995-12-01
Granted: 2003-05-21
Abstract: PCT No. PCT/AU95/00812 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Dec. 1, 1995 PCT Pub. No. WO96/17388 PCT Pub. Date Jun. 6, 1996A semiconductor structure and method of forming the structure, where a supporting substrate or superstrate provides the mechanical strength to support overlying thin active regions. The thin dielectric layer deposited over the substrate or superstrate serves to isolate the deposited layers from the substrate from optical, metallurgical and/or chemical perspectives. A seeding layer is then deposited, the seeding layer being of n-type silicon with appropriate treatments to give the desired large grain size. This layer may be crystallized as it is deposited, or may be deposited in amorphous form and then crystallized with further processing. A stack of alternating polarity layers of amorphous silicon or silicon alloy incorporating n-type or p-type dopants in the alternating layers is then deposited over the seeding layer. Solid phase crystallization is then performed to give the desired grain size of 3  mu m or larger which can be achieved by extended heating of the layers at low temperature.
Patent EP-0799354-B1 (EP)
Inventor: GREEN DAVID ROBERT
IPC: E04C5/12
Filed: 1995-12-20
Granted: 2000-08-23
Abstract: The invention relates to anchorage assemblies and in particular to anchorage assemblies having a novel wedge arrangement, wedges for use with anchorage assemblies and an anchorage member. In order to improve wedge performance in an anchorage assembly, a wedge (21) is provided having both internally (24) and externally (25) relieved portions to give a nose area (26) which is tapered to a greater extent than the rest of the wedge (21). Under normal load conditions, the wedge (21) behaves like a short wedge having no nose relief and is highly efficient. However, under high load or load limit conditions, the nose portion (26) of the wedge (21) is arranged to deform plastically so that fretting of the stressing element (23) gripped by the wedge (21) does not occur. As well as the high performance wedge, an improved anchorage member for the anchorage assembly is provided, the anchorage member having a number of steps (34-74). The provision of steps (34-74) in the anchorage member reduces the tendency for anchorage members to be drawn into prestressed concrete structures and reduces the bursting forces within such structures. The combination of an anchorage assembly having the improved wedge and improved anchorage member is a particularly effective and advantageous one.
Patent EP-0802900-B1 (EP)
Inventor: HESTER JACKSON B JR
IPC: A61K31/18
Filed: 1995-12-21
Granted: 2000-02-16
Abstract: (S)-Enantiomeric methanesulfonamides are structurally depicted by formula (I) or its pharmacologically acceptable salts where R3 is a C1-9 alkyl substituted with one fluorine atom. These compounds are useful as Class III antiarrhythmic agents without the undesirable side effect of polymorphic ventricular tachycardia (PVT) and are stable against rapid metabolism. Use of the compounds of formula (I) in the preparation of compositions for treating cardiac arrhythmias are also described.
Patent EP-0752470-B1 (EP)
Inventor: KIY THOMAS DR
IPC: C12M3/02
Filed: 1996-06-27
Granted: 2002-09-25
Abstract: Culture of ciliata is effected using a vessel with a magnetic core-contg. stirrer. This stirrer is suspended from the top of the vessel so that it does not touch the vessel base. It is driven by a magnetic field.
Patent EP-0754679-B1 (EP)
Inventor: WEISS STEFAN DR
IPC: C07C277/02
Filed: 1996-07-17
Granted: 1998-10-28
Abstract: Prepn. of creatine or creatine monohydrate comprises reaction of the sodium or potassium salt of sarcosine with cyanamide in water or a mixture of water and organic solvent at 20-150 degrees C and at pH 7.0-14.0. Reaction temp. is 50-100 degrees C, pH = 9.0-10.0 and acid regulated, molar ratio cyanamide:sarcosinate salt is 1:4-4:1 (pref. 0.9:1-1.25:1), sarcosine salt being present as a 35-45 wt.% aq. soln. and the cyanamide as pref. 50 wt.% aq. soln. Pref. organic solvent is a 1-5C aliphatic alcohol. Reaction product is purified by and recrystallised from water. Dry creatine product is less than 1 wt.% and the monohydrate has approx. 12.1 wt.% water content.
Patent EP-0737628-B1 (EP)
Inventor: BOUGAMONT JEAN-LOUIS
IPC: B65D83/00
Filed: 1996-04-12
Granted: 2000-07-26
Abstract: The packaging and distributor comprises a flexible deformable membrane (4), with an ejection hole (41), housed in the upper part of the product container (1). The membrane is sealed in its upper part by a cap (2) which passes axially through a tube forming a jet whose upper end (31) projects outside and whose lower internal end is supported on the membrane, sealing the hole. The membrane is constituted by an axial truncated valve (40) whose upper end has the ejection hole and whose lower edge is attached to a U section collar (42). The collar is extended upwards, the length of the internal wall of the container by a thin extensible skirt (43) connected in its upper part, by a fixing flange (44) onto the container.
Patent EP-0814793-B1 (EP)
Inventor: HENRY RICHARD A DR
IPC: A61K31/167
Filed: 1996-03-04
Granted: 2003-07-16
Abstract: Aerosol compositions used for anesthetizing mammals in both human and veterinary applications include prilocaine base solubilized in the hydrofluorocarbon (HFC) propellants 1,1,1,2-tetrafluoroethane and 1,1,1,2,3,3,3-heptafluoropropane. Prilocaine base has been found to be readily soluble in HFC propellants when combined in liquid or micro rod form, and a solution stable to temperatures as low as -82 DEG  C. is formed upon combination of the two components. In the aerosol compositions, the HFCs are the only propellants used. Additional pharmaceutical constituents can also be combined the the prilocaine base/HFC composition to provide a multi-component anesthetic, and it has been found that the presence of prilocaine in the combination can assist in solubilizing and/or suspending these pharmaceutical consituents. Some example pharmaceutical compositions within the practice of this invention include HFC, prilocaine base, and a pharmaceutical other prilocaine selected from the group consisting of bronchodilators, antiinflammatories, antitusives, vasoactive drugs, vasoconstrictors, antibiotics, peptides, steroids, enzymes, antihistamines, hormones, enzyme and receptor inhibitors and agonists, 5-aminolevulinic acid, antiseptics, disinfectants, procaine, cocaine, chloroprocaine, tetractaine, mepivacaine, lidocaine, bupivacaine, etidocaine, ropivacaine, benzocaine, and phenylephrine.
Patent EP-0814852-B1 (EP)
Inventor: KETHARANATHAN VETTIVETPILLAI
IPC: A61L27/48
Filed: 1996-03-08
Granted: 2003-08-06
Abstract: L'invention a pour objet un biomatériau prévu pour être utilisé en chirurgie sur l'homme. Il comprend une couche cohérente d'un tissu collagène non humain qui a été soumis à un tannage au glutaraldéhyde afin de comprendre des fibriles de collagène non réticulées, et un matériau de renforcement de synthèse encastré dans cette couche cohérente. Le matériau de synthèse présente une structure favorisant cet encastrement, la densité moyenne de cette structure étant in situ supérieure à 50 par centimètre carré. L'invention a également pour objet des améliorations d'un procédé de fabrication de biomatériaux consistant à favoriser la croissance d'un tissu collagène sur des structures en mailles recouvrant des surfaces de support implantées chez l'animal. Selon un aspect, une structure en mailles de fibres synthétiques tubulaires s'insère de manière lâche sur une tige ou un tube de support. Selon un autre aspect, on utilise un support formant feuille et le tissu se développant autour du support formant feuille est adapté pour former une poche, un sac ou une enveloppe de matériau collagène.
Patent EP-0828801-B1 (EP)
Inventor: FERENCZ ANDREAS
IPC: C09J167/02
Filed: 1996-05-22
Granted: 2004-10-27
Abstract: PCT No. PCT/EP96/02194 Sec. 371 Date Nov. 24, 1997 Sec. 102(e) Date Nov. 24, 1997 PCT Filed May 22, 1996 PCT Pub. No. WO96/37566 PCT Pub. Date Nov. 28, 1996The proposed process for bonding together two substrates with an anhydrous or low-water-content partially crystalline adhesive which is solid at room temperature is characterized in that the adhesive is first activated by internal and/or external friction. The substrates are then joined together with the adhesive between them. When allowed to stand, the structure attains its final strength after a period of between a few seconds to a few days. The friction destroys the crystalline structure and causes the adhesive to become gluey, and re-crystallization gives it its final strength and eliminates the gluey quality. The adhesive is based preferably on polyester or polyurethane and used preferably in the form of a gum stick without impermeable packaging. It is especially suitable for bonding paper, since it does not cause corrugation.
Patent EP-0826258-B1 (EP)
Inventor: NIGHAN WILLIAM L JR
IPC: A61F9/008
Filed: 1996-05-17
Granted: 2004-07-07
Abstract: Un laser à diode de pompage, à mode multiaxial et à faisceau doublé et triplé dans l'intracavité, comporte au moins deux miroirs résonateurs définissant une cavité de résonateur. Un cristal à laser (22, 56) et un cristal de doublement de la fréquence (36) sont positionnés dans une cavité du résonateur. Un cristal de triplement de la fréquence (80) est également positionné dans la cavité du résonateur. Une source de pompage à diode fournit un faisceau de pompage au cristal du laser et produit un faisceau de cristal de laser avec une pluralité de modes axiaux, arrivant sur le cristal de doublement de la fréquence produisant un faisceau de sortie à fréquence doublée. En outre, l'invention concerne un laser à diode de pompage, à mode multiaxial et à conversion non linéaire dans l'intracavité, comprenant au moins deux miroirs résonateurs définissant une cavité de résonateur, un cristal de laser et un appareil de conversion non linéaire positionné dans la cavité du résonateur. Un appareil de conversion non linéaire est également positionné dans la cavité du résonateur. Une source de pompage à diode fournit un faisceau de pompage au cristal du laser et produit un faisceau laser avec une pluralité de modes axiaux arrivant sur l'appareil de conversion non linéaire. Le résultat est un faisceau de sortie converti de manière non linéaire présentant une valeur moyenne quadratique de bruit inférieure à 3 %.
Patent EP-0846173-B1 (EP)
Inventor: LEVITT ROY CLIFFORD
IPC: C12N15/24
Filed: 1996-08-23
Granted: 2005-10-19
Abstract: The present invention relates to the use of an antibody, which is an anti-interleukin-9 antibody or an anti-interleukin-9 receptor antibody, that blocks interleukin-9 binding to the interleukin-9 receptor, for the preparation of a medicament for the reduction of bronchial hyper-responsiveness in a patient.